[1]陈 哲,李惠林,李增英,等.“miRNA—肾主骨—骨质疏松”相关性假说[J].医学争鸣,2018,(06):28-31.[doi:10.13276/j.issn.1674-8913.2018.06.008]
 CHEN Zhe,LI Huilin,LI Zengying,et al.A correlation hypothesis of “miRNA-kidney dominating bones-osteoporosis”[J].,2018,(06):28-31.[doi:10.13276/j.issn.1674-8913.2018.06.008]
点击复制

“miRNA—肾主骨—骨质疏松”相关性假说

参考文献/References:


[1] 朱飞鹏, 李冬华. 肾主骨理论的现代理解与补肾法研 究[J]. 上海中医药杂志, 2003, 37(6):9-11.
[2] 王 光, 杨 楠, 丁 寅, 等. MiR-21调控雌激素缺乏导 致的小鼠骨质疏松BMSCs成骨能力的研究[J]. 口腔生物 医学, 2015, 6(3):137-142.
[3] Zhao W, Dong Y, Wu C, et al. MiR-21 overexpression improves osteoporosis by targeting RECK[J]. Mol Cell Biochem, 2015, 405(1-2):125-133.
[4] 杨其芬, 邵秉一, 杨德琴, 等. miR-181a对骨质疏松小鼠 骨髓贴壁基质细胞体外增殖活性的影响[J]. 第三军医大 学学报, 2015, 37(19):1966-1971.
[5] 谢楚海, 史群伟, 郭剑鸿, 等. 雌激素缺乏条件下MiR-133 通过调控间充质干细胞成骨分化参与骨质疏松形成的 机制[J]. 中国老年学杂志, 2016, 36(13):3105-3107.
[6] 杜少华. miR-146a调控破骨细胞分化以及在老年性骨质 疏松症中的作用机制研究[D]. 杭州:浙江大学, 2016.
[7] 邹 璇. miR-182调控糖尿病性骨质疏松大鼠骨髓间充 质干细胞成骨分化的机制研究[D]. 北京:中国人民解放 军医学院, 2016.
[8] You L, Gu W, Chen L, et al. MiR-378 overexpression a t t e n u a t e s h i g h g l u c o s e - s u p p r e s s e d o s t e o g e n i c differentiation through targeting CASP3 and activating PI3K/Akt signaling pathway[J]. Int J Clin Exp Pathol, 2014, 7(10):7249-7261.
[9] Shi C, Huang P, Kang H, et al. Glucocorticoid inhibits cell proliferation in differentiating osteoblasts by microRNA- 199a targeting of WNT signaling[J]. J Mol Endocrinol, 2015, 54(3):325-337.
[10] 陈 立, 王小琴. 从骨形态发生蛋白-7探讨肾藏精理论的 物质基础[J]. 广州中医药大学学报, 2016, 33(5):736-740.
[11] Kureel J, Dixit M, Tyagi AM, et al. miR-542-3p suppresses osteoblast cell proliferation and differentiation, targets BMP- 7 signaling and inhibits bone formation[J]. Cell Death Dis, 2014, 5(2):e1050.
[12] Meng J, Zhang D, Pan N, et al. Identification of miR-194-5p as a potential biomarker for postmenopausal osteoporosis[J]. Peer J, 2015, 3(6973):e971.
[13] Cao Z, Moore BT, Wang Y, et al. MiR-422a as a potential cellular microRNA biomarker for postmenopausal osteoporosis[J]. PLoS One, 2014, 9(5):e97098.
[14] Wang Y, Li L, Moore BT, et al. MiR-133a in human circulating monocytes: a potential biomarker associated with postmenopausal osteoporosis[J]. PLoS One, 2012, 7(4):e34641.
[15] 陈 娟, 谢丽华, 李生强, 等. hsa-miR-655靶向调控绝经 后骨质疏松症肾阴虚证关联基因CLCF1的实验研究[J]. 中国骨质疏松杂志, 2016, 22(8):939-943.
[16] 赵 清, 赵可伟, 陈 迪, 等. 中药骨康治疗绝经后骨质 疏松症后全基因组miRNA表达谱研究[J]. 热带医学杂志, 2016, 16(4):418-422.

相似文献/References:

[1]万世勇,雷伟,吴子祥,等.复合bBMP的纤维蛋白胶对去势绵羊体内椎弓根螺钉固定的强化作用[J].医学争鸣,2007,(07):627.
 WAN Shi Yong,LEI Wei,WU Zi Xiang,et al.Augmentation of pedicle screw stability using fibrin sealant as a carrier compounded with bBMP in osteoporotic sheep vertebrae: in vivo biomechanical study[J].,2007,(06):627.
[2]段永宏,郭飞,厉孟.雷诺昔酚对去势后大鼠松质骨中TNFα表达及骨密度的影响[J].医学争鸣,2007,(10):881.
 DUAN Yong Hong,GUO Fei,LI Meng.Influence of raloxifene on expression of TNFα in cancellous bone and bone mineral density in ovariectomized rats[J].,2007,(06):881.
[3]饶海群,黄大江.心衰患者骨代谢的改变[J].医学争鸣,2007,(08):763.
[4]黄素然,罗二平,申广浩,等.电磁场对绝经后大鼠骨质疏松的影响[J].医学争鸣,2007,(06):481.
 HUANG Su Ran,LUO Er Ping,SHEN Guang Hao,et al.Effects of electromagnetic fields on osteoporosis in ovariectomized rats[J].,2007,(06):481.
[5]魏玉芳,王长海,刘钰林,等.补肾法对大鼠绝经后骨质疏松模型的影响[J].医学争鸣,2007,(06):544.
 WEI Yu Fang,WANG Chang Hai,LIU Yu Lin,et al.Therapeutic effect of invigorating kidney on postmenopausal osteoporosis in rats[J].,2007,(06):544.
[6]周日,刘建,孟国林.利塞膦酸钠对绝经后骨质疏松症患者血BGP及尿NTX/Cr的影响[J].医学争鸣,2009,(07):649.
 ZHOU Ri,LIU Jian,MENG Guo Lin.Effects of risedronate sodium on serum BGP and urine NTX/Cr in patients with postmenopausal osteoporosis[J].,2009,(06):649.
[7]杨彬奎,雷伟,王军,等.小牛椎体骨质疏松模型的快速建立[J].医学争鸣,2008,(12):1061.
 YANG Bin Kui,LEI Wei,WANG Jun,et al.Rapid modeling of vertebral osteoporosis in calf[J].,2008,(06):1061.
[8]罗二平,焦李成,申广浩,等.GZY型骨质疏松治疗仪的研制[J].医学争鸣,2006,(03):276.
 LUO Er Ping,JIAO Li Cheng,SHEN Guang Hao,et al.Development of GZY therapeutic instrument for osteoporosis[J].,2006,(06):276.
[9]赵莉,刘文利,刘艳,等.血管内皮损伤可能是血管钙化和骨质疏松的共同始动因素[J].医学争鸣,2017,(01):28.[doi:10.13276/j.issn.1674-8913.2017.01.006]
 ZHAO Li,LIU Wen-Li,LIU Yan,et al.Vascular endothelial dysfunction may be a common initialfactor of development of vascular calcification and osteoporosis[J].,2017,(06):28.[doi:10.13276/j.issn.1674-8913.2017.01.006]

备注/Memo

基金项目:深圳市科技研发基金(JCYJ20140408153331810,JCYJ20160428175316298)
通信作者:李惠林。Tel:13602666389,E-mail:sztcmlhl@163.com
作者简介:陈 哲。硕士生(导师李惠林)。研究方向:内分泌及代谢性疾病的中医基础与临床研究。Tel:18575522725,E-mail:cz960508271@163.com

更新日期/Last Update: 2018-11-30